Literature DB >> 15334091

A novel model of occlusive thrombus formation in mice.

Takeshi Sasaki1, Masafumi Kuzuya, Xian-Wu Cheng, Kae Nakamura, Norika Tamaya-Mori, Keiko Maeda, Shigeru Kanda, Teruhiko Koike, Kohji Sato, Akihisa Iguchi.   

Abstract

A novel model to induce occlusive thrombus formation was developed in mice in vivo. Mice were simultaneously treated with ligation and cuff placement at the left carotid artery. At 7 days after the treatment, occlusive thrombus was observed at the intracuff region, but not in the distal and proximal regions of the cuff, and not induced by a single treatment of ligation or cuff placement. The plasma levels of von Willebrand factor (vWF), which represent the endothelial status, were significantly increased in combined treatment of ligation and cuff placement 1 day after the operation. Whereas no significant changes in plasma vWF were observed in either single treatment of ligation or cuff placement. The expression of vWF, considered to be the endothelial marker, was detected on the luminal surface distal and proximal to the cuff and the carotid artery in the single treatment groups treated with either ligation or cuff placement, but was not detected in the intracuff region. Furthermore, the binding of Griffolia Simplicifolia Lectin-I (GSL-I) and endothelial nitric oxide synthase (eNOS) expression indicating the endothelial integrity was not detected in the intracuff region. Intermittent injections of ancrod, which decreases the plasma fibrinogen, inhibited occlusive thrombus formation in the intracuff region. The expression of eNOS was detected at the distal and proximal but not the intracuff region of the carotid artery treated with ancrod. Daily administration of aspirin significantly suppressed the thrombus formation in this model. These results indicate that occlusive thrombus formation accompanied by endothelial damage or dysfunction is induced by the combined application of ligation and cuff placement at the carotid artery, and suggest that this endothelial damage or dysfunction may be one pathogenesis of thrombogenesis in this model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334091     DOI: 10.1038/labinvest.3700171

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  4 in total

1.  Xanthohumol isolated from Humulus lupulus prevents thrombosis without increased bleeding risk by inhibiting platelet activation and mtDNA release.

Authors:  Guang Xin; Zeliang Wei; Chengjie Ji; Huajie Zheng; Jun Gu; Limei Ma; Wenfang Huang; Susan L Morris-Natschke; Jwu-Lai Yeh; Rui Zhang; Chaoyi Qin; Li Wen; Zhihua Xing; Yu Cao; Qing Xia; Ke Li; Hai Niu; Kuo-Hsiung Lee; Wen Huang
Journal:  Free Radic Biol Med       Date:  2017-02-08       Impact factor: 7.376

2.  Fabrication of an alpha-lipoic acid-eluting poly-(D,L-lactide-co-caprolactone) cuff for the inhibition of neointimal formation.

Authors:  Hyo Jeong Lee; Seung Hee Choi; Mun Hee Nah; Jeong Ok Lim; In Kyu Lee
Journal:  Exp Mol Med       Date:  2009-01-31       Impact factor: 8.718

3.  Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice.

Authors:  Leandro C F Lima; Marcella L Porto; Bianca P Campagnaro; Clarissa L Tonini; Breno V Nogueira; Thiago Mc Pereira; Elisardo C Vasquez; Silvana S Meyrelles
Journal:  Lipids Health Dis       Date:  2012-07-31       Impact factor: 3.876

Review 4.  Mast cells in vulnerable atherosclerotic plaques--a view to a kill.

Authors:  Ken A Lindstedt; Mikko I Mäyränpää; Petri T Kovanen
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.